RS

Raghubir Singh

Active Director Director DIN 10250518
DIN 10250518 First appointment Jul 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2023
Shareholding value •••• Premium profile

About Raghubir Singh

Data last updated:

Raghubir Singh is a Director at Grimarck Healthcare Private Limited (since 2023). Grimarck Healthcare Private Limited reported revenue of ₹39.9 Lakh (FY 2025).

DIN 10250518
Primary Designation Director
First Appointment 24 Jul 2023
Oldest Company Age 3 yrs
Largest company Grimarck Healthcare Private Limited · ₹39.9 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Grimarck Healthcare Private Limited U86100HR2023PTC113552
Director24 Jul 20232023₹39.9 Lakh (FY 2025)Active

Board colleagues of Raghubir Singh

Directorship timeline

Open interactive timeline →
Grimarck Healthcare Private Limited
Premium access

Shareholding and investment profile for Raghubir Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Raghubir Singh

Raghubir Singh currently holds 1 directorship: Grimarck Healthcare Private Limited (Director, since 24 Jul 2023, revenue ₹39.9 Lakh (FY 2025)).

Raghubir Singh was first appointed on 24 Jul 2023 as Director at Grimarck Healthcare Private Limited.

The current boards of Raghubir Singh's companies include Antima Chaturvedi (Grimarck Healthcare Private Limited), Mohan Chaturvedi (Grimarck Healthcare Private Limited), Rubal Kansal (Grimarck Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available